Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "AI"

7226 News Found

PMBJP has led to a total savings of Rs. 30,000 crore for citizens: Health Minister Nadda
Policy | March 03, 2025

PMBJP has led to a total savings of Rs. 30,000 crore for citizens: Health Minister Nadda

In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025


Biocon launches GLP -1, Liraglutide, in UK
News | March 01, 2025

Biocon launches GLP -1, Liraglutide, in UK

The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.


Healthcare Triangle announces $15.2 million PIPE offering
News | March 01, 2025

Healthcare Triangle announces $15.2 million PIPE offering

The PIPE offering consists of 36,190,476 units


Biocon Foundation marks 20 years of transforming lives
News | February 28, 2025

Biocon Foundation marks 20 years of transforming lives

Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives


Cupid receives Rs. 42 crore order from Tanzania
News | February 28, 2025

Cupid receives Rs. 42 crore order from Tanzania

We have big plans across our B2C and B2B businesses in India and abroad


Sanofi India declares 8% growth in net sales for Q4-2024
News | February 28, 2025

Sanofi India declares 8% growth in net sales for Q4-2024

Standalone profit from operations for Q4-2024 were Rs. 108 crore


Borosil Scientific to shift unit at Ambad to Bharuch
News | February 27, 2025

Borosil Scientific to shift unit at Ambad to Bharuch

This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials


USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit
Drug Approval | February 27, 2025

USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit

The observations issued are neither repeated observations nor related to data integrity


Briefs: Emcure and Relonchem
Drug Approval | February 27, 2025

Briefs: Emcure and Relonchem

USFDA inspection at Emcure Pharmaceuticals API facility


Senores Pharmaceuticals begins operations at greenfield API facility
News | February 27, 2025

Senores Pharmaceuticals begins operations at greenfield API facility

This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.